Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), bought 250,000 shares at $4.43 ($1.1M) on 2013-06-24, disclosed to the SEC on 2013-06-25.
Open-market purchase of $1.1M SNTA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.23 | 50,000 | $212K | 19.3% |
| 2 | $4.43 | 200,000 | $886K | 80.7% |
| Total | $4.39 avg | 250,000 | $1.1M | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |